Home / Import refusals / 1FX-3444821-6/30002/1

FDA Import Refusal 1FX-3444821-6/30002/1 — Cipla Ltd

Cipla Ltd — FEI 3011468843

The FDA refused shipment 1FX-3444821-6/30002/1 from Cipla Ltd (India) on April 17, 2026. The refused product falls under Drugs and Biologics — NORFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
April 17, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61GCK84 NORFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
Charges
118,75

Other import refusals

  • 1FX-5026714-5/20002/1 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-4357427-6/10002/4 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-5554870-4/30002/1 (Thu May 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-5209662-4/20002/1 (Wed May 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0349073-6/70002/1 (Mon May 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources